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VERSION 1 - REVIEW 
REVIEWER Lesley Wye 
University of Bristol  
Bristol, UK 
REVIEW RETURNED 07-Jul-2014 
 
GENERAL COMMENTS This is an interesting and well written paper detailing the history and 
development of commissioning support units and current challenges 
and opportunities. It offers a confident, informative narrative that 
helps to put many confusing, complex policy changes and their 
impact locally into a useful perspective. I would recommend its 
publication.  
Introduction – This starts with the establishment of the NHS and 
covers substantial ground to the present day. It is probably an 
editorial decision about whether eight pages of overview of history 
and policy changes leading to CSU are too many. From p.10 line 34 
to p13 line 10, I got a little lost. It was hard to keep in my head all the 
information about the different types of contracts and terminology. 
Do readers need all that detail? I would suggest that the authors 
keep what is necessary for discussion section. Regardless, these 
eight pages are well written and referenced.  
Methods – I am sure this is a high quality study, but the guidance for 
reviewers is to judge methods in light of the study being replicable 
elsewhere. Using this criterion, the methods section is a bit skimpy. 
Perhaps a fuller description of the methods has been published 
elsewhere. For example, there is not much information on how 
“research team members worked together on the analysis”, topic 
guides, how participants were selected within case sites, description 
of 8 case sites, how many of each type of participant e.g. GP, 
practice manager etc were interviewed? Were the GPs clinical 
commissioning leads or GPs who were members of the CCG but 
had no commissioning role? It would be good to know b/c assume 
that average practice manager/ GP might have little to say about 
commissioning support units. Did the list of themes emerge during 
meetings of the researcher team or CCG meetings? I‟m not sure 
what meetings are referred to. The statement about ethics approval 
is at the end of the paper. There is nothing about participant consent 
(another reviewer criterion).  
Results are presented well. Good choice of quotes and structure fits 
in well with introduction. Mainly interview data presented (unless 
survey data included quotes in text boxes – not clear). I‟m not sure 
the extent to which observations, documentation and survey data 
contributed to results.  
The discussion picks up many of the themes of the introduction. I 
would like a conclusion section, although realise this is not terribly 
usual in BMJ Open papers. There is so much information that hard 
to clarify exactly what the key message is. Also the paper rollicks 
along and then seems to stop rather abruptly. I found the conclusion 
in abstract really helpful. The paper needs strengths and limitations 
section in discussion, as per journal guidance.  
The paper is long at over 6k words. I found it interesting from 
beginning to end, but I am in this field and keen to learn whatever is 
possible about commissioning support units, given the paucity of 
literature to date. 
 
REVIEWER Catherine Pope 
University of Southampton UK 
 
External assessor of University promotion review for author 3 
(unpaid) 
REVIEW RETURNED 17-Jul-2014 
 
GENERAL COMMENTS I enjoyed reading about this important early study of the new 
commissioning processes. This is a case study across 8 CCGs and 
has a rich data set which has been well analysed. The paper 
provides an important historical account of this early moment in the 
new arrangements that will be of interest to those affected by this 
restructuring and therefore of interest to the audience of this journal.  
 
My comments are relatively minor aimed at polishing a good paper.  
 
The introduction is quite detailed and I wanted to get to the data and 
interpretation. It might be made a little snappier - for example is it 
necessary to have a paragraph on p8/9 explaining the NHSE 
decision making on private CSUs - could this be summarised with a 
more factual statement to the effect that „NHS E decided not to 
privatise or keep CSUs in public and opted for a model that provided 
some autonomy but protected public interest‟. The introduction also 
has a very slight negative/partisan „tone‟ (which I instinctively like as 
it chimes with my own view, and which „works‟ better in the 
discussion where it is linked to the analysis presented) - I wonder if a 
cool headed look at the wording might allow for an even more 
neutral opener - for example the paragraph on page 6 line 25 
contains several judgement statements and „might‟ be rephrased as 
“The New Labour Government (1997-2010) had encouraged PCTs 
to buy necessary specialist external support from the private 
sector.12,13 However a subsequent House of Commons Health 
Committee raised concerns about the value for money these 
arrangements offered, especially in the context of the economic 
downturn.14  
 
Some of the language and level of specialist knowledge from 
organisational studies in the introduction particularly p 9 onwards, 
could be scrutinised to see if it is absolutely necessary for the 
argument that follows. There were details there that I found 
interesting but I was not absolutely convinced that I needed to know 
in detail. In places where a shorter account might suffice - e.g. the 4 
organisational forms described on p8 line 13 are in reference no 21, 
so might just be summarised by name (e.g. „ Joint venture with other 
parties (taking the legal form of a company limited by shares)‟ 
Rather than having the longer description)?  
 
P6 line 40 change will to would  
P7 line 7 delete „to the reality of policy implementation‟  
P8 line 55 rephrase ? “selling CSUs was rejected because it did not 
have the support of CCGs (a necessary condition for the success of 
CSUs)”  
Page 9 line 31 change real to viable?  
P14 could you hint at your epistemological /theoretical orientation - 
perhaps referencing an approach - even if it is just to say it is 
ethnographic?  
 
Presumably a final version of this paper needs the full DH PRP 
disclaimer? 
 
REVIEWER Alison Porter 
Swansea University  
UK 
REVIEW RETURNED 20-Jul-2014 
 
GENERAL COMMENTS 1. I think that the research question/s could be tightened up a bit - 
particularly the first 'how did CCGs address the provision of 
commissioning support' I think is not clearly phrased.  
12. Study limitations - the authors do acknowledge that the situation 
is still in flux, but I wonder if more could be made of this. Also of the 
fact that the fieldwork was conducted before the new structures were 
in place, which adds to the uncertainties. 
 
a. The introduction section is quite lengthy. I think it would be clearer 
with a small bit of re-ordering - it would help if the section headed 
'make, buy, ally' came before the section specifically on CSUs. Also, 
I think it would be useful to move to the introdution the info currently 
on page 16 about per capita budget, and on p24 about the fact that 
CSUs are the preferred option until 2016.  
b. The concept of 'make, buy and ally' appears in the intro, but in the 
results there is discussion of 'make, buy and share'. I think the 
distinction between working closely with a CSU, and working closely 
with other CCGs to share commissioning support, has got slightly 
confused.  
c. It would be useful to have a little more about commissioning 
support tasks - what they are- set out earlier on the paper. 
 
VERSION 1 – AUTHOR RESPONSE 
Reviewer Name Lesley Wye  
Institution and Country University of Bristol  
 
 
Introduction – This starts with the establishment of the NHS and covers substantial ground to the 
present day. It is probably an editorial decision about whether eight pages of overview of history and 
policy changes leading to CSU are too many. From p.10 line 34 to p13 line 10, I got a little lost. It was 
hard to keep in my head all the information about the different types of contracts and terminology. Do 
readers need all that detail? I would suggest that the authors keep what is necessary for discussion 
section. Regardless, these eight pages are well written and referenced.  
 
We feel that given that the paper will be read by readers not necessarily familiar with the NHS and the 
recent changes, a slightly detailed explanation may be useful. We still tried to shorten slightly this 
section, however, by removing what we thought was not necessary.  
 
Methods – I am sure this is a high quality study, but the guidance for reviewers is to judge methods in 
light of the study being replicable elsewhere. Using this criterion, the methods section is a bit skimpy. 
Perhaps a fuller description of the methods has been published elsewhere. For example, there is not 
much information on how “research team members worked together on the analysis”, topic guides, 
how participants were selected within case sites, description of 8 case sites, how many of each type 
of participant e.g. GP, practice manager etc were interviewed? Were the GPs clinical commissioning 
leads or GPs who were members of the CCG but had no commissioning role? It would be good to 
know b/c assume that average practice manager/ GP might have little to say about commissioning 
support units. Did the list of themes emerge during meetings of the researcher team or CCG 
meetings? I‟m not sure what meetings are referred to. The statement about ethics approval is at the 
end of the paper. There is nothing about participant consent (another reviewer criterion).  
 
We refer the reader to the final report of the study where the methods are described in detail. We 
clarified the issue of data triangulation, ethical approval and obtaining consent.  
 
Results are presented well. Good choice of quotes and structure fits in well with introduction. Mainly 
interview data presented (unless survey data included quotes in text boxes – not clear). I‟m not sure 
the extent to which observations, documentation and survey data contributed to results.  
 
The contribution of observation of meetings and document analysis is explained in the Methods 
section.  
 
The discussion picks up many of the themes of the introduction. I would like a conclusion section, 
although realise this is not terribly usual in BMJ Open papers. There is so much information that hard 
to clarify exactly what the key message is. Also the paper rollicks along and then seems to stop rather 
abruptly. I found the conclusion in abstract really helpful. The paper needs strengths and limitations 
section in discussion, as per journal guidance.  
 
We added a conclusion.  
 
The paper is long at over 6k words. I found it interesting from beginning to end, but I am in this field 
and keen to learn whatever is possible about commissioning support units, given the paucity of 
literature to date.  
 
 
 
Reviewer Name Catherine Pope  
Institution and Country University of Southampton UK  
 
My comments are relatively minor aimed at polishing a good paper.  
 
The introduction is quite detailed and I wanted to get to the data and interpretation. It might be made a 
little snappier - for example is it necessary to have a paragraph on p8/9 explaining the NHSE decision 
making on private CSUs - could this be summarised with a more factual statement to the effect that 
„NHS E decided not to privatise or keep CSUs in public and opted for a model that provided some 
autonomy but protected public interest‟. The introduction also has a very slight negative/partisan „tone‟ 
(which I instinctively like as it chimes with my own view, and which „works‟ better in the discussion 
where it is linked to the analysis presented) - I wonder if a cool headed look at the wording might 
allow for an even more neutral opener - for example the paragraph on page 6 line 25 contains several 
judgement statements and „might‟ be rephrased as “The New Labour Government (1997-2010) had 
encouraged PCTs to buy necessary specialist external support from the private sector.12,13 However 
a subsequent House of Commons Health Committee raised concerns about the value for money 
these arrangements offered, especially in the context of the economic downturn.14  
 
We have rephrased or shortened these sections/sentences.  
 
Some of the language and level of specialist knowledge from organisational studies in the introduction 
particularly p 9 onwards, could be scrutinised to see if it is absolutely necessary for the argument that 
follows. There were details there that I found interesting but I was not absolutely convinced that I 
needed to know in detail. In places where a shorter account might suffice - e.g. the 4 organisational 
forms described on p8 line 13 are in reference no 21, so might just be summarised by name (e.g. „ 
Joint venture with other parties (taking the legal form of a company limited by shares)‟ Rather than 
having the longer description)?  
We have tried to shorten this section by removing two paragraphs and shortening the description on 
p.8.  
 
P6 line 40 change will to would  
P7 line 7 delete „to the reality of policy implementation‟  
P8 line 55 rephrase ? “selling CSUs was rejected because it did not have the support of CCGs (a 
necessary condition for the success of CSUs)”  
Page 9 line 31 change real to viable?  
P14 could you hint at your epistemological /theoretical orientation - perhaps referencing an approach - 
even if it is just to say it is ethnographic?  
 
We have made the changes suggested above.  
 
Presumably a final version of this paper needs the full DH PRP disclaimer?  
 
We have provided one.  
 
Reviewer Name Alison Porter  
Institution and Country Swansea University  
UK  
 
1. I think that the research question/s could be tightened up a bit - particularly the first 'how did CCGs 
address the provision of commissioning support' I think is not clearly phrased.  
 
We have tried to clarify the phrase.  
 
12. Study limitations - the authors do acknowledge that the situation is still in flux, but I wonder if more 
could be made of this. Also of the fact that the fieldwork was conducted before the new structures 
were in place, which adds to the uncertainties.  
 
We added a sentence to repeat the point in the section on the „development and future of CSUs‟.  
 
a. The introduction section is quite lengthy. I think it would be clearer with a small bit of re-ordering - it 
would help if the section headed 'make, buy, ally' came before the section specifically on CSUs.  
 
We retained the paper‟s structure as we believe that it is better to keep the development of the 
reforms in continuity rather than break them up with the section on „make, buy or ally‟.  
 
Also, I think it would be useful to move to the introdution the info currently on page 16 about per 
capita budget, and on p24 about the fact that CSUs are the preferred option until 2016.  
 
The reference on p. 16 regarding the £25 per capita budget is an elaboration of the point made earlier 
in the paper on p.9 that, „CCGs have been provided with a relatively small allowance to pay their 
running and managerial costs‟.  
Similarly we mention the fact that the intention is for CSUs to remain in the public sector until April 
2016 in the section on the „development of CSUs‟.  
 
b. The concept of 'make, buy and ally' appears in the intro, but in the results there is discussion of 
'make, buy and share'. I think the distinction between working closely with a CSU, and working closely 
with other CCGs to share commissioning support, has got slightly confused.  
 
We clarified at the beginning of the Findings section that the option of „ally‟ was not considered at the 
time of the research and explain why.  
 
c. It would be useful to have a little more about commissioning support tasks - what they are- set out 
earlier on the paper.  
 
We have added this information in the section on the „development of CSUs‟. 
